These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1952454)

  • 21. Cotrimoxazole as a potential effect modifier of the association between vitamin D status and risk of opportunistic infection among HIV-infected Tanzanian adults.
    Séraphin MN
    J Infect Dis; 2013 May; 207(10):1623. PubMed ID: 23440473
    [No Abstract]   [Full Text] [Related]  

  • 22. Agreement between clinical scoring systems used for the diagnosis of pediatric tuberculosis in the HIV era.
    Edwards DJ; Kitetele F; Van Rie A
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):263-9. PubMed ID: 17352090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [AIDS and tuberculosis].
    Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(2):97-108. PubMed ID: 2849196
    [No Abstract]   [Full Text] [Related]  

  • 24. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tuberculosis and anti-HIV seropositivity in Kinshasa, Zaire].
    Willame JC; Nkoko B; Pauwels P; Karhahunga C; Kaboto M; Jeugmans J; Burtonboy G; Prignot J
    Ann Soc Belg Med Trop; 1988 Jun; 68(2):165-7. PubMed ID: 3240013
    [No Abstract]   [Full Text] [Related]  

  • 26. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

  • 27. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The incidence and clinical presentation of tuberculosis in HIV-positive patients].
    Jolín Garijo L; González Vilas M; Parada Castellano R; Ojea de Castro R
    Aten Primaria; 1991 Apr; 8(4):310, 312-3. PubMed ID: 1751711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of HIV infection in paediatric admissions to a rural reference hospital in Bas-Zaire, July 1986-November 1989.
    Park R
    West Engl Med J; 1990 Sep; 105(3):83, 82. PubMed ID: 2093355
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-HIV-1 antibodies among young, unpaid blood donors from Goma, Northern Kivu, Zaire.
    Almaviva M; Welo K; Maganga W; Mukengeshay K; Piccioni I; Ceravolo C
    AIDS; 1990 Nov; 4(11):1162-3. PubMed ID: 2282194
    [No Abstract]   [Full Text] [Related]  

  • 31. [Incidence of infections with mycobacteria in HIV infected patients].
    Ruf B; Mauch H; Rüsch-Gerdes S; Schröder KH; Pohle HD; Brehmer W
    Pneumologie; 1990 Feb; 44 Suppl 1():451-2. PubMed ID: 2367434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Political and socioeconomic instability: how does it affect HIV? A case study in the Democratic Republic of Congo.
    Mulanga C; Bazepeo SE; Mwamba JK; Butel C; Tshimpaka JW; Kashi M; Lepira F; Caraël M; Peeters M; Delaporte E
    AIDS; 2004 Mar; 18(5):832-4. PubMed ID: 15075528
    [No Abstract]   [Full Text] [Related]  

  • 33. Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo.
    Yotebieng M; Wenzi LK; Basaki E; Batumbula ML; Tabala M; Mungoyo E; Mangala R; Behets F
    Pan Afr Med J; 2016; 25():161. PubMed ID: 28292123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection.
    Schulzer M; Fitzgerald JM; Enarson DA; Grzybowski S
    Tuber Lung Dis; 1992 Feb; 73(1):52-8. PubMed ID: 1525378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.
    Laga M; Icenogle JP; Marsella R; Manoka AT; Nzila N; Ryder RW; Vermund SH; Heyward WL; Nelson A; Reeves WC
    Int J Cancer; 1992 Jan; 50(1):45-8. PubMed ID: 1309459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection in patients with tuberculosis in Kinshasa, Zaire.
    Colebunders RL; Ryder RW; Nzilambi N; Dikilu K; Willame JC; Kaboto M; Bagala N; Jeugmans J; Muepu K; Francis HL
    Am Rev Respir Dis; 1989 May; 139(5):1082-5. PubMed ID: 2496632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis in epidemics of HIV/ AIDS and drug addiction].
    Volkova KI; Kokosov AN; Brazhenko NA
    Probl Tuberk; 2001; (2):61-5. PubMed ID: 11490477
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.
    Laga M; Manoka A; Kivuvu M; Malele B; Tuliza M; Nzila N; Goeman J; Behets F; Batter V; Alary M
    AIDS; 1993 Jan; 7(1):95-102. PubMed ID: 8442924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution to the study of tuberculosis control in the Belgian Congo].
    DACO
    Arch Belg Med Soc; 1951; 9(5-6):200-10. PubMed ID: 14857740
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin D: an adjunct to antiretroviral therapy?
    Martineau AR
    J Infect Dis; 2013 Feb; 207(3):373-5. PubMed ID: 23162134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.